Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Retained Earnings (2021 - 2025)

Zymeworks' Retained Earnings history spans 3 years, with the latest figure at -$8.3 million for Q3 2023.

  • For Q3 2023, Retained Earnings fell 24.61% year-over-year to -$8.3 million; the TTM value through Sep 2023 reached -$8.3 million, down 24.61%, while the annual FY2022 figure was -$6.7 million, 0.0% changed from the prior year.
  • Retained Earnings for Q3 2023 was -$8.3 million at Zymeworks, down from -$7.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$6.7 million in Q4 2021 and bottomed at -$583.1 million in Q1 2023.
  • The 3-year median for Retained Earnings is -$7.2 million (2021), against an average of -$103.2 million.
  • The largest annual shift saw Retained Earnings changed 0.0% in 2022 before it decreased 24.61% in 2023.
  • A 3-year view of Retained Earnings shows it stood at -$6.7 million in 2021, then changed by 0.0% to -$6.7 million in 2022, then decreased by 24.61% to -$8.3 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Retained Earnings are -$8.3 million (Q3 2023), -$7.8 million (Q2 2023), and -$583.1 million (Q1 2023).